Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension

M. H. Tayebjee, H. S. Lim, S. Nadar, R. J. MacFadyen, G. Y H Lip

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is associated with increased fibrosis of the extracellular matrix (ECM). Myocardial stiffness is a feature of diastolic dysfunction. We assessed circulating TIMP-1 as a marker of diastolic dysfunction in patients with type 2 diabetes mellitus (DM) and hypertension, who were compared with healthy controls. Methods: We recruited 54 patients (43 males; mean age 68 ± 5 years) with treated type 2 DM (i.e. controlled glycaemia, hypertension, hyperlipidaemia), 35 (30 males; 69 ± 8 years) treated nondiabetic hypertensives, and 31 healthy controls (18 males; 66 ± 5 years). Circulating TIMP-1 was measured by ELISA. Using transthoracic echocardiography, the early (E) diastolic mitral inflow velocity was measured with pulse wave Doppler, and the early mitral annular velocity (e′), a recognized index of diastolic relaxation, was measured with tissue Doppler. The E/A ratio was also calculated and isovolumic relaxation time measured. Results: Mean e′ levels differed significantly between controls, diabetics and hypertensives (P < 0.0001). Circulating TIMP-1 was significantly different between patients and controls (P = 0.006), but there was no statistically significant difference between the DM and hypertension group. In both groups, only e′ was negatively correlated with TIMP-1 levels, with a stronger correlation among the hypertensive patients (Spearman r = -0.544, P= 0.001) when compared with the diabetic group (r = -0.341, P = 0.011). Conclusion: Diastolic relaxation is impaired in diabetes and hypertensive patients. The relationship between TIMP-1 and e′ may reflect increased myocardial fibrosis and consequent diastolic dysfunction, which may be more prominent in hypertension.

Original languageEnglish
Pages (from-to)8-12
Number of pages5
JournalEuropean Journal of Clinical Investigation
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Tissue Inhibitor of Metalloproteinase-1
Medical problems
Type 2 Diabetes Mellitus
Tissue
Hypertension
Fibrosis
Echocardiography
Hyperlipidemias
Relaxation time
Extracellular Matrix
Pulse
Diabetes Mellitus
Enzyme-Linked Immunosorbent Assay
Stiffness

Keywords

  • Diabetes
  • Echocardiography
  • Extracellular matrix
  • Hypertension
  • Tissue doppler
  • Tissue inhibitor of metalloproteinase-1

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry
  • Clinical Biochemistry

Cite this

Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension. / Tayebjee, M. H.; Lim, H. S.; Nadar, S.; MacFadyen, R. J.; Lip, G. Y H.

In: European Journal of Clinical Investigation, Vol. 35, No. 1, 01.2005, p. 8-12.

Research output: Contribution to journalArticle

@article{cf71223dd9a04610ba6fab4165f3a3f3,
title = "Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension",
abstract = "Background: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is associated with increased fibrosis of the extracellular matrix (ECM). Myocardial stiffness is a feature of diastolic dysfunction. We assessed circulating TIMP-1 as a marker of diastolic dysfunction in patients with type 2 diabetes mellitus (DM) and hypertension, who were compared with healthy controls. Methods: We recruited 54 patients (43 males; mean age 68 ± 5 years) with treated type 2 DM (i.e. controlled glycaemia, hypertension, hyperlipidaemia), 35 (30 males; 69 ± 8 years) treated nondiabetic hypertensives, and 31 healthy controls (18 males; 66 ± 5 years). Circulating TIMP-1 was measured by ELISA. Using transthoracic echocardiography, the early (E) diastolic mitral inflow velocity was measured with pulse wave Doppler, and the early mitral annular velocity (e′), a recognized index of diastolic relaxation, was measured with tissue Doppler. The E/A ratio was also calculated and isovolumic relaxation time measured. Results: Mean e′ levels differed significantly between controls, diabetics and hypertensives (P < 0.0001). Circulating TIMP-1 was significantly different between patients and controls (P = 0.006), but there was no statistically significant difference between the DM and hypertension group. In both groups, only e′ was negatively correlated with TIMP-1 levels, with a stronger correlation among the hypertensive patients (Spearman r = -0.544, P= 0.001) when compared with the diabetic group (r = -0.341, P = 0.011). Conclusion: Diastolic relaxation is impaired in diabetes and hypertensive patients. The relationship between TIMP-1 and e′ may reflect increased myocardial fibrosis and consequent diastolic dysfunction, which may be more prominent in hypertension.",
keywords = "Diabetes, Echocardiography, Extracellular matrix, Hypertension, Tissue doppler, Tissue inhibitor of metalloproteinase-1",
author = "Tayebjee, {M. H.} and Lim, {H. S.} and S. Nadar and MacFadyen, {R. J.} and Lip, {G. Y H}",
year = "2005",
month = "1",
doi = "10.1111/j.1365-2362.2005.01438.x",
language = "English",
volume = "35",
pages = "8--12",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension

AU - Tayebjee, M. H.

AU - Lim, H. S.

AU - Nadar, S.

AU - MacFadyen, R. J.

AU - Lip, G. Y H

PY - 2005/1

Y1 - 2005/1

N2 - Background: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is associated with increased fibrosis of the extracellular matrix (ECM). Myocardial stiffness is a feature of diastolic dysfunction. We assessed circulating TIMP-1 as a marker of diastolic dysfunction in patients with type 2 diabetes mellitus (DM) and hypertension, who were compared with healthy controls. Methods: We recruited 54 patients (43 males; mean age 68 ± 5 years) with treated type 2 DM (i.e. controlled glycaemia, hypertension, hyperlipidaemia), 35 (30 males; 69 ± 8 years) treated nondiabetic hypertensives, and 31 healthy controls (18 males; 66 ± 5 years). Circulating TIMP-1 was measured by ELISA. Using transthoracic echocardiography, the early (E) diastolic mitral inflow velocity was measured with pulse wave Doppler, and the early mitral annular velocity (e′), a recognized index of diastolic relaxation, was measured with tissue Doppler. The E/A ratio was also calculated and isovolumic relaxation time measured. Results: Mean e′ levels differed significantly between controls, diabetics and hypertensives (P < 0.0001). Circulating TIMP-1 was significantly different between patients and controls (P = 0.006), but there was no statistically significant difference between the DM and hypertension group. In both groups, only e′ was negatively correlated with TIMP-1 levels, with a stronger correlation among the hypertensive patients (Spearman r = -0.544, P= 0.001) when compared with the diabetic group (r = -0.341, P = 0.011). Conclusion: Diastolic relaxation is impaired in diabetes and hypertensive patients. The relationship between TIMP-1 and e′ may reflect increased myocardial fibrosis and consequent diastolic dysfunction, which may be more prominent in hypertension.

AB - Background: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is associated with increased fibrosis of the extracellular matrix (ECM). Myocardial stiffness is a feature of diastolic dysfunction. We assessed circulating TIMP-1 as a marker of diastolic dysfunction in patients with type 2 diabetes mellitus (DM) and hypertension, who were compared with healthy controls. Methods: We recruited 54 patients (43 males; mean age 68 ± 5 years) with treated type 2 DM (i.e. controlled glycaemia, hypertension, hyperlipidaemia), 35 (30 males; 69 ± 8 years) treated nondiabetic hypertensives, and 31 healthy controls (18 males; 66 ± 5 years). Circulating TIMP-1 was measured by ELISA. Using transthoracic echocardiography, the early (E) diastolic mitral inflow velocity was measured with pulse wave Doppler, and the early mitral annular velocity (e′), a recognized index of diastolic relaxation, was measured with tissue Doppler. The E/A ratio was also calculated and isovolumic relaxation time measured. Results: Mean e′ levels differed significantly between controls, diabetics and hypertensives (P < 0.0001). Circulating TIMP-1 was significantly different between patients and controls (P = 0.006), but there was no statistically significant difference between the DM and hypertension group. In both groups, only e′ was negatively correlated with TIMP-1 levels, with a stronger correlation among the hypertensive patients (Spearman r = -0.544, P= 0.001) when compared with the diabetic group (r = -0.341, P = 0.011). Conclusion: Diastolic relaxation is impaired in diabetes and hypertensive patients. The relationship between TIMP-1 and e′ may reflect increased myocardial fibrosis and consequent diastolic dysfunction, which may be more prominent in hypertension.

KW - Diabetes

KW - Echocardiography

KW - Extracellular matrix

KW - Hypertension

KW - Tissue doppler

KW - Tissue inhibitor of metalloproteinase-1

UR - http://www.scopus.com/inward/record.url?scp=13244271256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244271256&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2005.01438.x

DO - 10.1111/j.1365-2362.2005.01438.x

M3 - Article

VL - 35

SP - 8

EP - 12

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 1

ER -